Preconditioning delays Ca2+-induced mitochondrial permeability transition

被引:145
作者
Argaud, L
Gateau-Roesch, O
Chalabreysse, L
Gomez, L
Loufouat, J
Thivolet-Béjui, F
Robert, D
Ovize, M
机构
[1] Univ Lyon 1, Lab Physiol Lyon Nord, INSERM E0226, F-69373 Lyon, France
[2] Hop Edouard Herriot, Dept Urgence & Reanimat Med, Lyon, France
[3] Hop Louis Pradel, Anat Pathol Lab, Lyon, France
关键词
preconditioning; calcium (cellular); mitochondria; apoptosis; necrosis;
D O I
10.1016/j.cardiores.2003.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We investigated whether ischemic preconditioning (PC) may modify mitochondrial permeability transition (MPT) pore opening. Methods: In protocol 1, New Zealand White rabbits underwent either no intervention (sham group) or 10 min of ischemia followed by 5 min of reperfusion, preceded (PC) or not (C; control) by one episode of 5 min of ischemia and 5 min of reperfusion. Rabbits were pretreated. by either saline or the MPT pore inhibitor cyclosporin A (CsA), or its non-immunosuppressive derivative Cs29 (10 mg/kg, IV bolus). Hearts were harvested and mitochondria isolated for further assessment of Ca2+-induced MPT using a Ca2+-sensitive micro-electrode. In protocol 2, C and PC hearts underwent 30 min of ischemia and 4 h of reperfusion. They were pretreated either by saline, CsA or Cs29, as in protocol 1. Infarct size was assessed by triphenyltetrazolium, and apoptosis by TUNEL staining. Results: In protocol 1, the Ca2+ overload required to induce MPT pore opening was significantly higher in PC than in C hearts. CsA and Cs29 significantly increased the Ca2+ overload required for MPT pore opening. In protocol 2, mean infarct size averaged 25% of the risk region in CsA/Cs29 treated hearts versus 15% in PC and 55% in controls (P<0.05 vs. C, P = ns vs. PC). Cardiomyocyte apoptosis was significantly reduced by PC and cyclosporin treatment with a mean apoptotic index of less than 2% in either group versus more than 11% in controls. Conclusion: This suggests that delayed opening of MPT pore may play a major role in ischemic PC. (C) 2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:115 / 122
页数:8
相关论文
共 42 条
  • [31] STRETCH PRECONDITIONS CANINE MYOCARDIUM
    OVIZE, M
    KLONER, RA
    PRZYKLENK, K
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (01): : H137 - H146
  • [32] Ischemic preconditioning decreases apoptosis in rat hearts in vivo
    Piot, CA
    Padmanaban, D
    Ursell, PC
    Sievers, RE
    Wolfe, CL
    [J]. CIRCULATION, 1997, 96 (05) : 1598 - 1604
  • [33] MECHANISM OF PRECONDITIONING - IONIC ALTERATIONS
    STEENBERGEN, C
    PERLMAN, ME
    LONDON, RE
    MURPHY, E
    [J]. CIRCULATION RESEARCH, 1993, 72 (01) : 112 - 125
  • [34] Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion
    Vanden Hoek, TL
    Becker, LB
    Shao, ZH
    Li, CQ
    Schumacker, PT
    [J]. CIRCULATION RESEARCH, 2000, 86 (05) : 541 - 548
  • [35] VIVALDI MT, 1985, AM J PATHOL, V121, P522
  • [36] Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811
    Waldmeier, PC
    Feldtrauer, JJ
    Qian, T
    Lemasters, JJ
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (01) : 22 - 29
  • [37] Preconditioning limits mitochondrial Ca2+ during ischemia in rat hearts:: role of KATP channels
    Wang, LG
    Cherednichenko, G
    Hernandez, L
    Halow, J
    Camacho, SA
    Figueredo, V
    Schaefer, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (05): : H2321 - H2328
  • [38] Downregulation of protein kinase C inhibits activation of mitochondrial KATP channels by diazoxide
    Wang, YG
    Takashi, E
    Xu, MF
    Ayub, A
    Ashraf, M
    [J]. CIRCULATION, 2001, 104 (01) : 85 - 90
  • [39] Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia
    Weinbrenner, C
    Liu, GS
    Downey, JM
    Cohen, MV
    [J]. CARDIOVASCULAR RESEARCH, 1998, 38 (03) : 676 - 684
  • [40] Wharton D., 1967, METHODS ENZYMOL, V10, P245, DOI DOI 10.1016/0076-6879(67)10048-7